Personal information

Activities

Employment (1)

Michael E DeBakey VA Medical Center: Houston, TX, US

2006 to present | Staff Psychiatrist (Mental Health)
Employment
Source: Self-asserted source
Thomas R. Kosten

Education and qualifications (1)

Baylor College of Medicine: Houston, TX, US

2006-07-01 to present | MD/Professor (Psychiatry)
Education
Source: Self-asserted source
Thomas R. Kosten

Funding (29)

Methamphetamine vaccine for Humans

2017-09-01 to 2018-04-30 | Grant
National Institute on Drug Abuse (Bethesda, US)
GRANT_NUMBER: R42DA043311
Source: Self-asserted source
Thomas R. Kosten via DimensionsWizard

Complementary Combination Therapy for Cocaine Dependence

2015-05-01 to 2018-03-31 | Grant
National Institute on Drug Abuse (Bethesda, US)
GRANT_NUMBER: R01DA035513
Source: Self-asserted source
Thomas R. Kosten via DimensionsWizard

Human methamphetamine vaccine: Translational Avante Garde Award

2011-09-30 to 2016-08-31 | Grant
National Institute on Drug Abuse (Rockville, US)
GRANT_NUMBER: 5DP1DA033502-04
GRANT_NUMBER: 5DP1DA033502-04
Source: Self-asserted source
Thomas R. Kosten via DimensionsWizard

Developing Immunotherapeutics for Methamphetamine Abuse

2009-08-01 to 2012-07-31 | Grant
National Institute on Drug Abuse (Bethesda, US)
GRANT_NUMBER: U01DA023898
Source: Self-asserted source
Thomas R. Kosten via DimensionsWizard

Multisite Controlled Trial of Cocaine Vaccine (1of 6) Lead Site/ Houston Treatmen

2008-09-15 to 2015-01-31 | Grant
National Institute on Drug Abuse (Bethesda, US)
GRANT_NUMBER: R01DA025223
Source: Self-asserted source
Thomas R. Kosten via DimensionsWizard

Tropisetron with Risperidone for Schizophrenia

2007-03-01 to 2011-02-28 | Grant
National Institute of Mental Health (Bethesda, US)
GRANT_NUMBER: U01MH079639
Source: Self-asserted source
Thomas R. Kosten via DimensionsWizard

Kappa Opioid Antagonist for Cocaine Addiction

2005-09-01 to 2013-12-31 | Grant
National Institute on Drug Abuse (Bethesda, US)
GRANT_NUMBER: U19DA021002
Source: Self-asserted source
Thomas R. Kosten via DimensionsWizard

Heroin Addiction Treatment: Naltrexone and Lofexidine

2004-09-28 to 2011-05-31 | Grant
National Institute on Drug Abuse (Bethesda, US)
GRANT_NUMBER: R01DA018863
Source: Self-asserted source
Thomas R. Kosten via DimensionsWizard

Stimulant Pharmacotherapy: Noradrenergic Targets

2004-09-27 to 2015-05-31 | Grant
National Institute on Drug Abuse (Bethesda, US)
GRANT_NUMBER: P50DA018197
Source: Self-asserted source
Thomas R. Kosten via DimensionsWizard

Cocaine Vaccine for Methadone Maintained Patients

2002-09-27 to 2007-06-30 | Grant
National Institute on Drug Abuse (Bethesda, US)
GRANT_NUMBER: R01DA015477
Source: Self-asserted source
Thomas R. Kosten via DimensionsWizard

NOVEL PHARMACOTHERAPY FOR TREATMENT OF COCAINE ADDICTION

2000-09-30 to 2010-05-31 | Grant
National Institute on Drug Abuse (Bethesda, US)
GRANT_NUMBER: U19DA013326
Source: Self-asserted source
Thomas R. Kosten via DimensionsWizard

11TH - 15TH ANNUAL MEETINGS AND SYMPOSIA

2000-09-30 to 2002-08-31 | Grant
National Institute on Drug Abuse (Bethesda, US)
GRANT_NUMBER: R13DA013380
Source: Self-asserted source
Thomas R. Kosten via DimensionsWizard

Comorbidity in Cocaine and Opioid Pharmacotherapy

2000-04-01 to 2011-02-28 | Grant
National Institute on Drug Abuse (Bethesda, US)
GRANT_NUMBER: K05DA000454
Source: Self-asserted source
Thomas R. Kosten via DimensionsWizard

COCAINE PHARMACOTHERAPIES FOR COMORBID POPULATIONS

1999-09-30 to 2005-02-28 | Grant
National Institute on Drug Abuse (Bethesda, US)
GRANT_NUMBER: P50DA012762
Source: Self-asserted source
Thomas R. Kosten via DimensionsWizard

9TH/13TH ANNUAL MEETING AND SYMPOSIUM

1998-09-05 to 2001-08-31 | Grant
National Institute on Drug Abuse (Rockville, US)
GRANT_NUMBER: 5R13DA012147-02
GRANT_NUMBER: 5R13DA012147-02
Source: Self-asserted source
Thomas R. Kosten via DimensionsWizard

THERAPEUTIC COCAINE VACCINE

1997-05-01 to 2005-12-31 | Grant
National Institute on Drug Abuse (Bethesda, US)
GRANT_NUMBER: U19DA010946
Source: Self-asserted source
Thomas R. Kosten via DimensionsWizard

YALE MEDICATIONS DEVELOPMENT RESEARCH CENTER

1994-09-30 to 1999-09-30 | Grant
National Institute on Drug Abuse (Bethesda, US)
GRANT_NUMBER: P50DA009250
Source: Self-asserted source
Thomas R. Kosten via DimensionsWizard

REDUCING HIV RISK IN METHADONE-MAINTAINED PATIENTS

1993-09-30 to 2003-12-31 | Grant
National Institute on Drug Abuse (Bethesda, US)
GRANT_NUMBER: R01DA008754
Source: Self-asserted source
Thomas R. Kosten via DimensionsWizard

SMALL INSTRUMENTATION GRANT

1993-09-15 to 1994-08-31 | Grant
National Institute on Drug Abuse (Bethesda, US)
GRANT_NUMBER: S15DA008671
Source: Self-asserted source
Thomas R. Kosten via DimensionsWizard

Molecular Neurobiology of Drug Addiction

1993-08-01 to 2018-12-31 | Grant
National Institute on Drug Abuse (Bethesda, US)
GRANT_NUMBER: P01DA008227
Source: Self-asserted source
Thomas R. Kosten via DimensionsWizard

THE YALE UNIVERSITY SUBSTANCE ABUSE RESEARCH CENTER

1991-09-30 to 1994-09-29 | Grant
National Institute on Drug Abuse (Bethesda, US)
GRANT_NUMBER: C06DA007837
Source: Self-asserted source
Thomas R. Kosten via DimensionsWizard

REDUCING AIDS RISKS

1989-09-30 to 1994-08-31 | Grant
National Institute on Drug Abuse (Bethesda, US)
GRANT_NUMBER: R18DA006190
Source: Self-asserted source
Thomas R. Kosten via DimensionsWizard

Pharmacotherapy for opioid and cocaine dependence

1988-08-01 to 2007-05-31 | Grant
National Institute on Drug Abuse (Bethesda, US)
GRANT_NUMBER: R01DA005626
Source: Self-asserted source
Thomas R. Kosten via DimensionsWizard

AGONIST TO ANTAGONIST--NEW APPROACHES

1987-09-01 to 1997-07-31 | Grant
National Institute on Drug Abuse (Rockville, US)
GRANT_NUMBER: 5K02DA000112-09
GRANT_NUMBER: 5K02DA000112-09
Source: Self-asserted source
Thomas R. Kosten via DimensionsWizard

PHARMACOTHERAPY OF IV COCAINE USE IN METHADONE PATIENTS

1987-07-01 to 1991-07-31 | Grant
National Institute on Drug Abuse (Bethesda, US)
GRANT_NUMBER: R01DA004505
Source: Self-asserted source
Thomas R. Kosten via DimensionsWizard

PHARMACOTHERAPY OF IV COCAINE USE IN METHADONE PATIENTS

1987-07-01 to 1991-07-31 | Grant
National Institute on Drug Abuse (Rockville, US)
GRANT_NUMBER: 5R01DA004505-03
GRANT_NUMBER: 5R01DA004505-03
Source: Self-asserted source
Thomas R. Kosten via DimensionsWizard

AGONIST TO ANTAGONIST--NEW APPROACHES

1987-03-01 to 1997-07-31 | Grant
National Institute on Drug Abuse (Bethesda, US)
GRANT_NUMBER: K02DA000112
Source: Self-asserted source
Thomas R. Kosten via DimensionsWizard

CLINICAL RESEARCH CENTER FOR OPIOID AND COCAINE ABUSE

1986-08-01 to 2000-11-30 | Grant
National Institute on Drug Abuse (Bethesda, US)
GRANT_NUMBER: P50DA004060
Source: Self-asserted source
Thomas R. Kosten via DimensionsWizard

CLINICAL RESEARCH CENTER FOR OPIOID AND COCAINE ABUSE

1986-08-01 to 2000-11-30 | Grant
National Institute on Drug Abuse (Rockville, US)
GRANT_NUMBER: 5P50DA004060-13
GRANT_NUMBER: 5P50DA004060-13
Source: Self-asserted source
Thomas R. Kosten via DimensionsWizard